Drug recall · November 23, 2022
Phenoxybenzamine Hydrochloride Capsules recall
Why: Failed Impurities/Degradation Specifications
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Phenoxybenzamine Hydrochloride Capsules, USP 10mg, 100-count bottles, RX only Dist. by: Par Pharmaceutical Chestnut Ridge, NY 10977 U.S.A. Mfg. by: Par Forumulations Private Limited,9/215, Pudupakkam, Kelambakkam - 603 103. NDC 49884-038-01
- Lots / codes
Lot #: 15429401, Exp. Date 08/2023
- Quantity
- 218 bottles/100 capsules per bottle
- Company
- Par Formulations Private Limited, Chennai, N/A
- Distribution
- Nationwide within the United States
- Initiated
- November 10, 2022 · Voluntary: Firm initiated
- Classified
- November 15, 2022
- Reported
- November 23, 2022
- Ended
- August 18, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Phenoxybenzamine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.